The purpose of this extension study is to assess the safety and tolerability of secukinumab when administered long-term in patients with polymyalgia rheumatica.
- Investigator
- Roland Staud
- Ages
- 50 Years - 100 Years
- Sexes
- All
Clinical trials
-
A multi-center, open-label extension study of subcutaneous secukinumab to evaluate the long-term